Subscribe To
Acrivon Therapeutics Announces Pricing of Initial Public Offering
WATERTOWN, Mass., Nov. 14, 2022 (GLOBE NEWSWIRE) — Acrivon Therapeutics, Inc. (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biopharmaceutical company developing precision oncology medicines that it matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proprietary proteomics-based patient responder identification platform, today announced the pricing […] The post Acrivon Therapeutics Announces Pricing of Initial Public O...
Read More
Posted: Nov 15 2022, 03:16
Author Name: forextv
Views: 110781